Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It does not affect the study information shown on this record.
    Difference
    0.8%
    Check dated 2026-10-21T21:56:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-14T22:00:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-07T22:11:49.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study record history, representing an update to the version list. An older revision entry v3.6.6 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-09-16T22:02:59.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The history now shows a new revision tag—v3.6.6—replacing v3.6.5. This indicates a site-wide version update rather than a modification to the study data.
    Difference
    0.1%
    Check dated 2026-09-02T19:52:01.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision (v3.6.5) was added to the study record history, replacing the previous revision (v3.6.4) in the history log.
    Difference
    0.1%
    Check dated 2026-08-11T19:26:10.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.